Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 May 18;82(12):1967–1973. doi: 10.1054/bjoc.2000.1150

Tissue factor, osteopontin, αvβ3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression

S Takano 1, K Tsuboi 1, Y Tomono 1, Y Mitsui 2, T Nose 1
PMCID: PMC2363244  PMID: 10864205

Abstract

Vascular endothelial growth factor (VEGF) is a potent angiogenic factor in human gliomas. VEGF-induced proteins in endothelial cells, tissue factor (TF), osteopontin (OPN) and αvβ3 integrin have been implicated as important molecules by which VEGF promotes angiogenesis in vivo. Sixty-eight gliomas were immunohistochemically stained with TF, VEGF, OPN and αvβ3 integrin antibody. Twenty-three tumours, six normal brains and nine glioma cell lines were evaluated for their mRNA expression of VEGF and TF by reverse transcription polymerase chain reaction analysis. The data indicated that TF as well as VEGF was a strong regulator of human glioma angiogenesis. First, TF expression in endothelial cells which was observed in 74% of glioblastomas, 54% of anaplastic astrocytomas and none of low-grade astrocytomas, correlated with the microvascular density of the tumours. Double staining for VEGF and TF demonstrated co-localization of these two proteins in the glioblastoma tissues. Second, there was a correlation between TF and VEGF mRNA expression in the glioma tissues. Third, glioma cell conditioned medium containing a large amount of VEGF up-regulated the TF mRNA expression in human umbilical vein endothelial cells. OPN and αvβ3 integrin, were also predominantly observed in the microvasculature of glioblastomas associated with VEGF expression. Microvascular expression of these molecules could be an effective antiangiogenesis target for human gliomas. © 2000 Cancer Research Campaign

Keywords: angiogenesis, glioma, osteopontin, tissue factor, vascular endothelial growth factor, αVβ3 integrin

Full Text

The Full Text of this article is available as a PDF (308.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brem S., Cotran R., Folkman J. Tumor angiogenesis: a quantitative method for histologic grading. J Natl Cancer Inst. 1972 Feb;48(2):347–356. [PubMed] [Google Scholar]
  2. Brooks P. C., Clark R. A., Cheresh D. A. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science. 1994 Apr 22;264(5158):569–571. doi: 10.1126/science.7512751. [DOI] [PubMed] [Google Scholar]
  3. Brooks P. C., Montgomery A. M., Rosenfeld M., Reisfeld R. A., Hu T., Klier G., Cheresh D. A. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 1994 Dec 30;79(7):1157–1164. doi: 10.1016/0092-8674(94)90007-8. [DOI] [PubMed] [Google Scholar]
  4. Brown L. F., Papadopoulos-Sergiou A., Berse B., Manseau E. J., Tognazzi K., Perruzzi C. A., Dvorak H. F., Senger D. R. Osteopontin expression and distribution in human carcinomas. Am J Pathol. 1994 Sep;145(3):610–623. [PMC free article] [PubMed] [Google Scholar]
  5. Carmeliet P., Mackman N., Moons L., Luther T., Gressens P., Van Vlaenderen I., Demunck H., Kasper M., Breier G., Evrard P. Role of tissue factor in embryonic blood vessel development. Nature. 1996 Sep 5;383(6595):73–75. doi: 10.1038/383073a0. [DOI] [PubMed] [Google Scholar]
  6. Contrino J., Hair G., Kreutzer D. L., Rickles F. R. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med. 1996 Feb;2(2):209–215. doi: 10.1038/nm0296-209. [DOI] [PubMed] [Google Scholar]
  7. Dvorak H. F., Brown L. F., Detmar M., Dvorak A. M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995 May;146(5):1029–1039. [PMC free article] [PubMed] [Google Scholar]
  8. Folkman J., Shing Y. Angiogenesis. J Biol Chem. 1992 Jun 5;267(16):10931–10934. [PubMed] [Google Scholar]
  9. Gladson C. L. Expression of integrin alpha v beta 3 in small blood vessels of glioblastoma tumors. J Neuropathol Exp Neurol. 1996 Nov;55(11):1143–1149. doi: 10.1097/00005072-199611000-00005. [DOI] [PubMed] [Google Scholar]
  10. Hamada K., Kuratsu J., Saitoh Y., Takeshima H., Nishi T., Ushio Y. Expression of tissue factor correlates with grade of malignancy in human glioma. Cancer. 1996 May 1;77(9):1877–1883. doi: 10.1002/(SICI)1097-0142(19960501)77:9<1877::AID-CNCR18>3.0.CO;2-X. [DOI] [PubMed] [Google Scholar]
  11. Hamuro T., Kamikubo Y., Nakahara Y., Miyamoto S., Funatsu A. Human recombinant tissue factor pathway inhibitor induces apoptosis in cultured human endothelial cells. FEBS Lett. 1998 Jan 16;421(3):197–202. doi: 10.1016/s0014-5793(97)01559-7. [DOI] [PubMed] [Google Scholar]
  12. Kim K. J., Li B., Winer J., Armanini M., Gillett N., Phillips H. S., Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature. 1993 Apr 29;362(6423):841–844. doi: 10.1038/362841a0. [DOI] [PubMed] [Google Scholar]
  13. Koomägi R., Volm M. Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis. Int J Cancer. 1998 Feb 20;79(1):19–22. doi: 10.1002/(sici)1097-0215(19980220)79:1<19::aid-ijc4>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  14. Kumar R., Yoneda J., Bucana C. D., Fidler I. J. Regulation of distinct steps of angiogenesis by different angiogenic molecules. Int J Oncol. 1998 Apr;12(4):749–757. doi: 10.3892/ijo.12.4.749. [DOI] [PubMed] [Google Scholar]
  15. Millauer B., Shawver L. K., Plate K. H., Risau W., Ullrich A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature. 1994 Feb 10;367(6463):576–579. doi: 10.1038/367576a0. [DOI] [PubMed] [Google Scholar]
  16. Ng S. Y., Gunning P., Eddy R., Ponte P., Leavitt J., Shows T., Kedes L. Evolution of the functional human beta-actin gene and its multi-pseudogene family: conservation of noncoding regions and chromosomal dispersion of pseudogenes. Mol Cell Biol. 1985 Oct;5(10):2720–2732. doi: 10.1128/mcb.5.10.2720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ollivier V., Bentolila S., Chabbat J., Hakim J., de Prost D. Tissue factor-dependent vascular endothelial growth factor production by human fibroblasts in response to activated factor VII. Blood. 1998 Apr 15;91(8):2698–2703. [PubMed] [Google Scholar]
  18. Ott I., Fischer E. G., Miyagi Y., Mueller B. M., Ruf W. A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J Cell Biol. 1998 Mar 9;140(5):1241–1253. doi: 10.1083/jcb.140.5.1241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Plate K. H., Breier G., Weich H. A., Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature. 1992 Oct 29;359(6398):845–848. doi: 10.1038/359845a0. [DOI] [PubMed] [Google Scholar]
  20. Pötgens A. J., Lubsen N. H., van Altena G., Schoenmakers J. G., Ruiter D. J., de Waal R. M. Measurement of tissue factor messenger RNA levels in human endothelial cells by a quantitative RT-PCR assay. Thromb Haemost. 1994 Feb;71(2):208–213. [PubMed] [Google Scholar]
  21. Saitoh Y., Kuratsu J., Takeshima H., Yamamoto S., Ushio Y. Expression of osteopontin in human glioma. Its correlation with the malignancy. Lab Invest. 1995 Jan;72(1):55–63. [PubMed] [Google Scholar]
  22. Scarpati E. M., Wen D., Broze G. J., Jr, Miletich J. P., Flandermeyer R. R., Siegel N. R., Sadler J. E. Human tissue factor: cDNA sequence and chromosome localization of the gene. Biochemistry. 1987 Aug 25;26(17):5234–5238. doi: 10.1021/bi00391a004. [DOI] [PubMed] [Google Scholar]
  23. Senger D. R., Ledbetter S. R., Claffey K. P., Papadopoulos-Sergiou A., Peruzzi C. A., Detmar M. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Am J Pathol. 1996 Jul;149(1):293–305. [PMC free article] [PubMed] [Google Scholar]
  24. Senger D. R. Molecular framework for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines. Am J Pathol. 1996 Jul;149(1):1–7. [PMC free article] [PubMed] [Google Scholar]
  25. Shoji M., Hancock W. W., Abe K., Micko C., Casper K. A., Baine R. M., Wilcox J. N., Danave I., Dillehay D. L., Matthews E. Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol. 1998 Feb;152(2):399–411. [PMC free article] [PubMed] [Google Scholar]
  26. Takano S., Gately S., Engelhard H., Tsanaclis A. M., Brem S. Suramin inhibits glioma cell proliferation in vitro and in the brain. J Neurooncol. 1994;21(3):189–201. doi: 10.1007/BF01063768. [DOI] [PubMed] [Google Scholar]
  27. Takano S., Gately S., Jiang J. B., Brem S. A diaminoantraquinone inhibitor of angiogenesis. J Pharmacol Exp Ther. 1994 Nov;271(2):1027–1033. [PubMed] [Google Scholar]
  28. Takano S., Gately S., Neville M. E., Herblin W. F., Gross J. L., Engelhard H., Perricone M., Eidsvoog K., Brem S. Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator. Cancer Res. 1994 May 15;54(10):2654–2660. [PubMed] [Google Scholar]
  29. Takano S., Yoshii Y., Kondo S., Suzuki H., Maruno T., Shirai S., Nose T. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res. 1996 May 1;56(9):2185–2190. [PubMed] [Google Scholar]
  30. Weindel K., Marmé D., Weich H. A. AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor. Biochem Biophys Res Commun. 1992 Mar 31;183(3):1167–1174. doi: 10.1016/s0006-291x(05)80313-4. [DOI] [PubMed] [Google Scholar]
  31. Zagzag D. Angiogenic growth factors in neural embryogenesis and neoplasia. Am J Pathol. 1995 Feb;146(2):293–309. [PMC free article] [PubMed] [Google Scholar]
  32. Zhang Y., Deng Y., Luther T., Müller M., Ziegler R., Waldherr R., Stern D. M., Nawroth P. P. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest. 1994 Sep;94(3):1320–1327. doi: 10.1172/JCI117451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Zucker S., Mirza H., Conner C. E., Lorenz A. F., Drews M. H., Bahou W. F., Jesty J. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Int J Cancer. 1998 Mar 2;75(5):780–786. doi: 10.1002/(sici)1097-0215(19980302)75:5<780::aid-ijc19>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES